Q&A clinic Human variations web-based electronic Application Form (eAF) for non-CAPs, Online, European Medicines Agency, Amsterdam, the Netherlands, from 25 October 2024, 10:00 (CEST) to 25 October 2024, 10:30 (CEST)

Human medicines European public assessment report (EPAR): Zavicefta, ceftazidime,avibactam, Date of authorisation: 23/06/2016, Revision: 17, Status: Authorised

Minutes of the CAT meeting 11-12 September 2024

European Medicines Agency (EMA) Patients' and Consumers' (PCWP) and Healthcare Professionals' (HCPWP) Working Parties meeting with all eligible organisations - 2024, Online, European Medicines Agency, Amsterdam, the Netherlands, 20 November 2024

Highlights - Tenth Industry Standing Group (ISG) meeting

Orphan designation: adeno-associated virus vector serotype SAN011 encoding a microRNA against DMPK mRNA Treatment of dystrophic myotonia type 1, 11/10/2024 Positive

HMA/EMA multi-stakeholder workshop on artificial intelligence (AI) - enabling the safe and responsible use of AI, Online, European Medicines Agency, Amsterdam, the Netherlands, Broadcast, from 5 November 2024, 09:00 (CET) to 5 November 2024, 17:40 (CET)

Informative webinar on PMS Product User Interface usage and key actions for Marketing Authorisation Holders (with demo), Online, Amsterdam, the Netherlands, from 29 October 2024, 10:00 (CET) to 29 October 2024, 12:00 (CET)

European Shortages Monitoring Platform (ESMP) training session on routine shortage reporting for marketing authorisation holders of CAPs, Online, European Medicines Agency, Amsterdam, the Netherlands, Broadcast, from 20 November 2024, 10:00 (CET) to 20 November 2024, 12:00 (CET)

Human medicines European public assessment report (EPAR): Yorvipath, Palopegteriparatide, Date of authorisation: 17/11/2023, Revision: 3, Status: Authorised